These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 29197233)

  • 1. Cholinergic anti-inflammatory pathway inhibits neointimal hyperplasia by suppressing inflammation and oxidative stress.
    Li DJ; Fu H; Tong J; Li YH; Qu LF; Wang P; Shen FM
    Redox Biol; 2018 May; 15():22-33. PubMed ID: 29197233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.
    Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P
    Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation.
    Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X
    Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide inhibits neointimal hyperplasia following vascular injury via differential, cell-specific modulation of SOD-1 in the arterial wall.
    Bahnson ES; Koo N; Cantu-Medellin N; Tsui AY; Havelka GE; Vercammen JM; Jiang Q; Kelley EE; Kibbe MR
    Nitric Oxide; 2015 Jan; 44():8-17. PubMed ID: 25460325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinic ACh receptor α7 inhibits PDGF-induced migration of vascular smooth muscle cells by activating mitochondrial deacetylase sirtuin 3.
    Li DJ; Tong J; Zeng FY; Guo M; Li YH; Wang H; Wang P
    Br J Pharmacol; 2019 Nov; 176(22):4388-4401. PubMed ID: 30270436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α7 Nicotinic Acetylcholine Receptor Relieves Angiotensin II-Induced Senescence in Vascular Smooth Muscle Cells by Raising Nicotinamide Adenine Dinucleotide-Dependent SIRT1 Activity.
    Li DJ; Huang F; Ni M; Fu H; Zhang LS; Shen FM
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1566-76. PubMed ID: 27339462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α7 Nicotinic acetylcholine receptor contributes to the alleviation of lung ischemia-reperfusion injury by transient receptor potential vanilloid type 1 stimulation.
    Li X; Xu Y; Cheng Y; Wang R
    J Surg Res; 2018 Oct; 230():164-174. PubMed ID: 30100034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baroreflex deficiency aggravates atherosclerosis via α7 nicotinic acetylcholine receptor in mice.
    Chen L; Liu DH; Zhang X; Zhang EH; Liu C; Su DF; Cai GJ
    Vascul Pharmacol; 2016 Dec; 87():92-99. PubMed ID: 27568460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of Long Pentraxin PTX3 Promoted Neointimal Hyperplasia after Vascular Injury.
    Ishino M; Shishido T; Suzuki S; Katoh S; Sasaki T; Funayama A; Netsu S; Hasegawa H; Honda S; Takahashi H; Arimoto T; Miyashita T; Miyamoto T; Watanabe T; Takeishi Y; Kubota I
    J Atheroscler Thromb; 2015; 22(4):372-8. PubMed ID: 25342475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha7 nicotinic acetylcholine receptor activation attenuated intestine-derived acute lung injury.
    He Y; Ye ZQ; Li X; Zhu GS; Liu Y; Yao WF; Luo GJ
    J Surg Res; 2016 Apr; 201(2):258-65. PubMed ID: 27020805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-19 reduces ligation-mediated neointimal hyperplasia by reducing vascular smooth muscle cell activation.
    Ellison S; Gabunia K; Richards JM; Kelemen SE; England RN; Rudic D; Azuma YT; Munroy MA; Eguchi S; Autieri MV
    Am J Pathol; 2014 Jul; 184(7):2134-43. PubMed ID: 24814101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphigosine-1-phosphate receptor 1 promotes neointimal hyperplasia in a mouse model of carotid artery injury.
    Kitano T; Usui S; Takashima SI; Inoue O; Goten C; Nomura A; Yoshioka K; Okajima M; Kaneko S; Takuwa Y; Takamura M
    Biochem Biophys Res Commun; 2019 Mar; 511(1):179-184. PubMed ID: 30777331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural anti-inflammatory action mediated by two types of acetylcholine receptors in the small intestine.
    Kimura H; Imura YK; Tomiyasu H; Mihara T; Kaji N; Ohno K; Unno T; Tanahashi Y; Jan TR; Tsubone H; Ozaki H; Hori M
    Sci Rep; 2019 Apr; 9(1):5887. PubMed ID: 30971711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT4 deficiency protects against neointima formation following arterial injury in mice.
    Lv L; Meng Q; Ye M; Wang P; Xue G
    J Mol Cell Cardiol; 2014 Sep; 74():284-94. PubMed ID: 24933129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of neointima hyperplasia by the combined therapy of linagliptin and metformin via AMPK/Nox4 signaling in diabetic rats.
    Zhang WX; Tai GJ; Li XX; Xu M
    Free Radic Biol Med; 2019 Nov; 143():153-163. PubMed ID: 31369842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2-derived prostaglandin E₂ promotes injury-induced vascular neointimal hyperplasia through the E-prostanoid 3 receptor.
    Zhang J; Zou F; Tang J; Zhang Q; Gong Y; Wang Q; Shen Y; Xiong L; Breyer RM; Lazarus M; Funk CD; Yu Y
    Circ Res; 2013 Jul; 113(2):104-14. PubMed ID: 23595951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of VAChT reduction and α7nAChR stimulation by PNU-282987 in lung inflammation in a model of chronic allergic airway inflammation.
    Pinheiro NM; Miranda CJCP; Santana FR; Bittencourt-Mernak M; Arantes-Costa FM; Olivo C; Perini A; Festa S; Caperuto LC; Tibério IFLC; Prado MAM; Martins MA; Prado VF; Prado CM
    Eur J Pharmacol; 2020 Sep; 882():173239. PubMed ID: 32619677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmembrane protein 66 attenuates neointimal hyperplasia after carotid artery injury by SOCE inactivation.
    Yang J; Li S; Wang Q; Yang D
    Mol Med Rep; 2019 Aug; 20(2):1436-1442. PubMed ID: 31173198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia.
    Ko DS; Kang J; Heo HJ; Kim EK; Kim K; Kang JM; Jung Y; Baek SE; Kim YH
    Int J Biol Sci; 2022; 18(13):5154-5167. PubMed ID: 35982907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-1 Restricts Vascular Smooth Muscle Cell Motility Via Modulating Adhesion Force and Focal Adhesion Dynamics.
    Tsai MS; Chiang MT; Tsai DL; Yang CW; Hou HS; Li YR; Chang PC; Lin HH; Chen HY; Hwang IS; Wei PK; Hsu CP; Lin KI; Liu FT; Chau LY
    Sci Rep; 2018 Jul; 8(1):11497. PubMed ID: 30065303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.